Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-20 04:34 | 2024-01-19 | MYCB | My City Builders, Inc. | Pittilloni Francis | Director, 10% owner | Real Estate | BUY | $950,000.00 | 3,800,000 | $3,610,000,000,000 | 3,822,713 | +16,730.5% |
| 2024-01-20 04:19 | 2024-01-19 | MYCB | My City Builders, Inc. | Goodell Yolanda | Director, Officer, 10% owner - Vice President | Real Estate | BUY | $950,000.00 | 3,800,000 | $3,610,000,000,000 | 3,822,713 | +16,730.5% |
| 2024-01-20 00:37 | 2024-01-17 | PSBD | Palmer Square Capital BDC Inc. | Bicknell Martin C | 10% owner | Other | BUY | $16.45 | 607,902 | $9,999,988 | 1,391,817 | +77.5% |
| 2024-01-20 02:02 | 2024-01-17 | KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $12.55 | 143,605 | $1,801,597 | 4,459,651 | +3.3% |
| 2024-01-20 04:21 | 2024-01-17 | TALO | TALOS ENERGY INC. | Control Empresarial de Capitales S.A. de C.V. | 10% owner, Other | Crude Petroleum & Natural Gas | BUY | $11.70 | 19,658,119 | $229,999,992 | 34,747,781 | +130.3% |
| 2024-01-20 00:11 | 2024-01-17 | PBF | PBF Energy Inc. | Control Empresarial de Capitales S.A. de C.V. | 10% owner, Other | Petroleum Refining | BUY | $41.57 | 500,000 | $20,784,550 | 14,332,998 | +3.6% |
| 2024-01-19 02:22 | 2024-01-17 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $16.15 | 161,121 | $2,602,169 | 24,677,027 | +0.7% |
| 2024-01-19 02:16 | 2024-01-17 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.93 | 139,777 | $2,086,186 | 17,164,362 | +0.8% |
| 2024-01-19 02:13 | 2024-01-17 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.16 | 198,401 | $1,421,325 | 44,116,615 | +0.5% |
| 2024-01-18 00:01 | 2024-01-16 | MRAI | Marpai, Inc. | Lamendola Damien | Director, Officer, 10% owner - Chief Executive Officer | Services-Misc Health & Allied Services, NEC | BUY | $0.92 | 1,100,000 | $1,012,110 | 1,951,306 | +129.2% |
| 2024-01-18 01:22 | 2024-01-12 | CELU | Celularity Inc | Lim Kok Thay | 10% owner | Pharmaceutical Preparations | BUY | $0.25 | 21,410,983 | $5,331,335 | 51,473,762 | +71.2% |
| 2024-01-18 03:06 | 2023-12-11 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $5.00 | 1,000,000 | $5,000,000 | 18,202,009 | +5.8% |
| 2024-01-18 00:20 | 2024-01-12 | PBF | PBF Energy Inc. | Control Empresarial de Capitales S.A. de C.V. | 10% owner, Other | Petroleum Refining | BUY | $42.77 | 1,256,000 | $53,714,850 | 13,832,998 | +10.0% |
| 2024-01-18 05:39 | 2024-01-12 | LSXMA | Liberty Media Corp | BERKSHIRE HATHAWAY INC | 10% owner | Television Broadcasting Stations | BUY | $30.43 | 1,203,024 | $36,606,456 | 22,501,458 | +5.6% |
| 2024-01-18 05:33 | 2024-01-12 | LSXMK | Liberty Media Corp | BERKSHIRE HATHAWAY INC | 10% owner | Television Broadcasting Stations | BUY | $30.40 | 1,591,168 | $48,364,347 | 46,468,678 | +3.5% |
| 2024-01-17 00:06 | 2024-01-12 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $17.95 | 445,788 | $8,000,016 | 33,833,121 | +1.3% |
| 2024-01-16 23:54 | 2024-01-12 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $17.95 | 390,064 | $7,000,014 | 17,248,713 | +2.3% |
| 2024-01-17 01:21 | 2024-01-12 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $16.27 | 102,677 | $1,670,555 | 24,515,906 | +0.4% |
| 2024-01-17 01:17 | 2024-01-12 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $15.21 | 165,662 | $2,520,531 | 17,024,585 | +1.0% |
| 2024-01-17 01:13 | 2024-01-12 | BCAT | BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.96 | 157,211 | $2,351,877 | 13,813,243 | +1.2% |
| 2024-01-12 21:42 | 2024-01-10 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $16.33 | 76,559 | $1,249,948 | 24,413,229 | +0.3% |
| 2024-01-12 21:33 | 2024-01-11 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $15.17 | 72,085 | $1,093,529 | 16,858,923 | +0.4% |
| 2024-01-13 01:01 | 2024-01-11 | SLDB | Solid Biosciences Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $5.53 | 904,160 | $5,000,005 | 4,192,216 | +27.5% |
| 2024-01-13 00:46 | 2024-01-10 | KYN | Kayne Anderson Energy Infrastructure Fund, Inc. | MetLife Investment Management, LLC | 10% owner | Other | BUY | $12,500,000.00 | 25,000,000 | $312,500,000,000,000 | 0 | +100.0% |
| 2024-01-12 20:04 | 2024-01-10 | ACAX | HWH International Inc. | WOLVERINE ASSET MANAGEMENT LLC | Other | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $10.66 | 200,165 | $2,133,759 | 0 | +100.0% |
| 2024-01-13 01:15 | 2024-01-11 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $5.53 | 3,410,713 | $18,861,243 | 6,833,539 | +99.6% |
| 2024-01-12 00:31 | 2024-01-09 | DYN | Dyne Therapeutics, Inc. | Kersten Dirk | Director, 10% owner | Pharmaceutical Preparations | BUY | $17.50 | 1,714,285 | $29,999,988 | 1,428,571 | +100.0% |
| 2024-01-12 00:00 | 2024-01-09 | EYPT | EyePoint, Inc. | Cormorant Asset Management, LP | 10% owner | Laboratory Analytical Instruments | BUY | $19.94 | 855,000 | $17,051,094 | 6,893,235 | +14.2% |
| 2024-01-10 18:14 | 2024-01-05 | VOXX | N/A | Downing Steven R | Director | Other | BUY | $10.00 | 1,568,750 | $15,687,500 | 3,311,308 | +90.0% |
| 2024-01-10 18:06 | 2023-10-06 | VOXX | N/A | Downing Steven R | Director | Other | BUY | $10.00 | 1,568,750 | $15,687,500 | 1,742,558 | +902.6% |
| 2024-01-10 20:54 | 2024-01-09 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $16.32 | 73,695 | $1,202,702 | 24,336,670 | +0.3% |
| 2024-01-11 03:20 | 2024-01-08 | SNMP | N/A | Stonepeak GP Holdings LP | 10% owner, Other | Other | BUY | $1.39 | 1,536,220 | $2,134,270 | 1,536,220 | +100.0% |
| 2024-01-11 03:19 | 2024-01-08 | SNMP | N/A | Evolve Transition Infrastructure GP LLC | 10% owner | Other | BUY | $1.39 | 1,536,220 | $2,134,270 | 1,536,220 | +100.0% |
| 2024-01-11 04:57 | 2024-01-08 | KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $12.54 | 137,700 | $1,726,455 | 4,289,800 | +3.3% |
| 2024-01-11 02:56 | 2023-12-18 | LPSN | LIVEPERSON INC | Vector Capital Management, L.P. | 10% owner | Services-Prepackaged Software | BUY | $3.49 | 1,805,569 | $6,294,214 | 10,899,456 | +19.9% |
| 2024-01-09 02:32 | 2024-01-05 | N/A | Nuveen Churchill Direct Lending Corp. | TEACHERS INSURANCE & ANNUITY ASSOCIATION OF AMERICA | 10% owner | Other | BUY | $18.05 | 870,267 | $15,708,319 | 5,148,416 | +20.3% |
| 2024-01-08 20:06 | 2024-01-05 | VOXX | N/A | Downing Steven R | Director | Other | BUY | $10.00 | 1,568,750 | $15,687,500 | 3,312,558 | +90.0% |
| 2024-01-08 16:54 | 2024-01-05 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner - CEO & Chairman | Pharmaceutical Preparations | BUY | $0.90 | 1,500,000 | $1,344,600 | 203,456,694 | +0.7% |
| 2024-01-06 03:07 | 2024-01-03 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | Ophthalmic Goods | BUY | $28.61 | 226,553 | $6,481,568 | 10,764,388 | +2.1% |
| 2024-01-04 17:37 | 2024-01-02 | N-A | N/A | Manulife Private Credit Plus Fund | 10% owner | Other | BUY | $20.25 | 197,531 | $4,000,003 | 793,827 | +33.1% |
| 2024-01-04 23:18 | 2024-01-02 | N-A | N/A | Manulife Private Credit Plus Fund | 10% owner | Other | BUY | $21.01 | 713,946 | $15,000,005 | 1,435,259 | +99.0% |
| 2024-01-04 19:35 | 2024-01-02 | N-A | N/A | John Hancock Life & Health Insurance Co | 10% owner | Other | BUY | $20.25 | 197,531 | $4,000,003 | 793,827 | +33.1% |
| 2024-01-04 17:58 | 2024-01-02 | N-A | N/A | Manulife Reinsurance (Bermuda) LTD | 10% owner | Other | BUY | $20.25 | 493,827 | $9,999,997 | 1,984,568 | +33.1% |
| 2024-01-04 22:38 | 2024-01-02 | N-A | N/A | Manulife Private Credit Plus Fund | 10% owner | Other | BUY | $20.25 | 246,914 | $5,000,009 | 1,245,985 | +24.7% |
| 2024-01-05 00:10 | 2023-12-11 | N/A | N/A | Saudi National Bank | 10% owner | Other | BUY | $20.00 | 321,466 | $6,429,325 | 816,166 | +65.0% |
| 2024-01-05 03:52 | 2024-01-02 | N/A | N/A | Solotar Joan | Director | Other | BUY | $25.00 | 200,000 | $5,000,000 | 200,000 | +100.0% |
| 2024-01-04 19:45 | 2024-01-02 | N-A | N/A | JOHN HANCOCK LIFE INSURANCE CO USA | 10% owner | Other | BUY | $20.25 | 98,765 | $1,999,991 | 396,913 | +33.1% |
| 2024-01-05 05:32 | 2024-01-02 | LSXMK | N/A | BERKSHIRE HATHAWAY INC | 10% owner | Other | BUY | $29.76 | 1,669,219 | $49,675,791 | 44,877,510 | +3.9% |
| 2024-01-05 05:26 | 2024-01-02 | LSXMA | N/A | BERKSHIRE HATHAWAY INC | 10% owner | Other | BUY | $29.76 | 1,090,754 | $32,461,821 | 21,298,434 | +5.4% |
| 2024-01-03 17:38 | 2024-01-02 | N/A | N/A | UAW Chrysler Retirees Medical Benefits Plan | 10% owner | Other | BUY | $10.50 | 4,761,905 | $50,000,003 | 17,785,812 | +36.6% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.